India aims for Rs 17,000 crore investment in pharma R&D by FY28 through PRIP scheme, focusing on innovation and growth.

Join Dr. Raymond A. Huml, Vice President of Rare Strategy, Sciensus; Andrew Cummins, Vice President of Business Development, Sciensus; and Kirsty Hoyle, CEO, Metabolic Support UK, for the live webinar ...

PTC Therapeutics could boost revenue with vatiquinone for Friedreich's ataxia. Find out why PTCT stock is poised for growth ...

While the IRA architects were building their anti-innovation government drug pricing plan, they also included a provision to ...

The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Plus Therapeutics’ injectable ...

Small-Cap Firms Dominate Market Rally. In this article, we are going to take a look at where Plus Therapeutics, Inc.

Shares of Plus Therapeutics, Inc. PSTV were up a whopping 311.4% on March 6 after the company announced that the FDA has ...

The FDA granted orphan drug status to rhenium-186 obisbemeda for treating leptomeningeal metastases in lung cancer.

Plus Therapeutics stock rises after peer-reviewed publication of Phase 1 glioma data and FDA Orphan Drug Designation for lung ...

However, fresh evidence from the HHS’ watchdog shows the problem is not a pushover FDA. If anything, the problem is a ...

The stock makes the NASDAQ top percentage gainer list on FDA news. The stock is trading at $1.3500, up $1.0000, gaining ...

ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...